Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure
Authors
Keywords
-
Journal
Dermatology and Therapy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-21
DOI
10.1007/s13555-019-00340-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
- (2018) F. Valenzuela et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled Phase 3b Study of Patients with Moderate-to-Severe Genital Psoriasis
- (2018) C. Ryan et al. BRITISH JOURNAL OF DERMATOLOGY
- CME Part I Psoriasis: Which Therapy for Which Patient Psoriasis comorbidities and preferred systemic agents
- (2018) Shivani B. Kaushik et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- CME Part II Psoriasis: Which Therapy for Which Patient Focus on special populations and chronic infections
- (2018) Shivani B. Kaushik et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Anti-inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis
- (2018) J.J. Wu et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota
- (2018) Ce Tang et al. NATURE IMMUNOLOGY
- Comprehensive Long-Term Safety of Adalimumab from Eighteen Clinical Trials in Adult Patients With Moderate to Severe Plaque Psoriasis
- (2018) C. Leonardi et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: An integrated analysis from 11 clinical trials
- (2018) R G Langley et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials
- (2017) Kristian Reich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data
- (2017) Bruce Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
- (2016) Stephan R Targan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
- (2016) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psoriasis
- (2015) Wolf-Henning Boehncke et al. LANCET
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
- (2015) Christopher E M Griffiths et al. LANCET
- Psoriasis prevalence among adults in the United States
- (2014) Tara D. Rachakonda et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- (2013) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Immunity to infection in IL-17-deficient mice and humans
- (2012) Sophie Cypowyj et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
- (2011) Renata Micha et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis
- (2011) Craig Leonardi et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
- (2011) Nehal N. Mehta et al. AMERICAN JOURNAL OF MEDICINE
- The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study
- (2011) K. Abuabara et al. BRITISH JOURNAL OF DERMATOLOGY
- Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
- (2011) Warren Strober et al. GASTROENTEROLOGY
- IL-17 signaling in host defense against Candida albicans
- (2011) Sarah L. Gaffen et al. IMMUNOLOGIC RESEARCH
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.
- (2010) K Abuabara et al. BRITISH JOURNAL OF DERMATOLOGY
- Pharmacologic Immunomodulation and Cutaneous Malignancy in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis
- (2010) M. S. KRATHEN et al. JOURNAL OF RHEUMATOLOGY
- Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population
- (2010) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
- (2010) S. L. Westlake et al. RHEUMATOLOGY
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database
- (2009) N. N. Mehta et al. EUROPEAN HEART JOURNAL
- Precarious Balance: Th17 Cells in Host Defense
- (2009) A. Peck et al. INFECTION AND IMMUNITY
- Psoriasis and Risk of Incident Cancer: An Inception Cohort Study with a Nested Case–Control Analysis
- (2009) Yolanda B. Brauchli et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatments for psoriasis and the risk of malignancy
- (2009) Rita V. Patel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A protective function for interleukin 17A in T cell–mediated intestinal inflammation
- (2009) William O'Connor Jr et al. NATURE IMMUNOLOGY
- The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
- (2009) S. L. Westlake et al. RHEUMATOLOGY
- Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis
- (2008) J.A. Kaye et al. BRITISH JOURNAL OF DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started